Search results
Results from the WOW.Com Content Network
Farber disease (also known as Farber's lipogranulomatosis, acid ceramidase deficiency, "Lipogranulomatosis", [2] and ASAH1-related disorders) is an extremely rare, progressive, autosomal recessive lysosomal storage disease caused by a deficiency of the acid ceramidase enzyme.
Lipid storage diseases can be inherited two ways: Autosomal recessive inheritance occurs when both parents carry and pass on a copy of the faulty gene, but neither parent show signs and symptoms of the condition and is not affected by the disorder. Each child born to these parents have a 25 percent chance of inheriting both copies of the ...
An eponymous disease is a disease, disorder, condition, or syndrome named after a person, usually the physician or other health care professional who first identified the disease; less commonly, a patient who had the disease; rarely, a literary character who exhibited signs of the disease or an actor or subject of an allusion, as characteristics associated with them were suggestive of symptoms ...
It is a sister site to The Free Dictionary and usage examples in the form of "references in classic literature" taken from the site's collection are used on The Free Dictionary 's definition pages. In addition, double-clicking on a word in the site's collection of reference materials brings up the word's definition on The Free Dictionary.
Mosby's Dictionary of Medicine, Nursing & Health Professions is a dictionary of health-related topics. The 8th edition, published in 2009, contains 2,240 pages and 2,400 colour illustrations. It includes some encyclopaedic definitions and 12 appendixes containing reference information. [1]
Cherry-red spot as seen here in Tay–Sachs disease, caused by the fovea's center appearing bright red because it is surrounded by a whiter than usual area. Metabolic Storage Diseases:, [6] [7] Tay–Sachs disease; Farber disease; GM1 and GM2 gangliosidoses; Metachromatic leukodystrophy; Niemann–Pick disease; Sandhoff disease; Sialidosis
Enzyme replacement therapy is available to treat mainly Fabry disease and Gaucher disease, and people with these types of sphingolipidoses may live well into adulthood. The other types are generally fatal by age 1 to 5 years for infantile forms, but progression may be mild for juvenile- or adult-onset forms.
In 2018, he was awarded a 5-year $3.3 million NIH grant for researching novel pharmaceuticals and diseases associated with altered levels of lipoproteins. [4] In 2002, together with Jamie Shuda he developed an outreach program named BioEYES which allowed students to gain hands-on biology experience by studying live zebrafish in the classroom.